scholarly journals Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey

2012 ◽  
Vol 10 (1) ◽  
pp. 46 ◽  
Author(s):  
Tone Brit Østhus ◽  
Valjbona Preljevic ◽  
Leiv Sandvik ◽  
Torbjørn Leivestad ◽  
Inger Nordhus ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Health Related Quality ◽  
Short Form Health Survey ◽  
Dialysis Patients ◽  
Form Health ◽  
Related Quality ◽  
Health Related ◽  
Short Form Health

scholarly journals Medida do impacto da doença: validade de constructo de instrumento entre coronariopatas

2013 ◽  
Vol 47 (4) ◽  
pp. 843-851 ◽  
Author(s):  
Rafaela Batista dos Santos Pedrosa ◽  
Roberta Cunha Matheus Rodrigues ◽  
Kátia Melissa Padilha ◽  
Maria Cecília B.J. Gallani ◽  
Neusa Maria Costa Alexandre
Keyword(s):  
Short Form ◽  
Health Related Quality ◽  
Short Form Health Survey ◽  
Medical Study ◽  
Form Health ◽  
Sf 36 ◽  
Related Quality ◽  
Health Related ◽  
Short Form Health

Este estudo estimou a validade de constructo pelo teste de grupos conhecidos do Instrumento para Mensuração do Impacto da Doença no Cotidiano do Valvopata (IDCV) quanto a sinais e sintomas, função ventricular sistólica, fração de ejeção do ventrículo esquerdo (FEVE) e qualidade de vida relacionada à saúde (QVRS) em 153 coronariopatas em seguimento ambulatorial. Os dados foram obtidos pela aplicação do IDCV e das versões brasileiras do The Medical Study 36-item Short Form Health Survey – SF-36 e MacNew Heart Disease Health-related Quality of Life Questionnair e. Foi utilizado o teste de Mann-Whitney para verificar a capacidade do IDCV em discriminar o impacto quanto a sinais e sintomas, FEVE e disfunção sistólica ventricular, bem como o teste de Kruskal-Wallis para verificar seu poder de discriminação em relação à QVRS. Constatou-se que o IDCV discriminou o impacto entre aqueles que pontuaram nos quartis (≤Q1, Q1-Q3, ≥Q3) de QVRS. Os achados deste estudo contribuem para o refinamento do IDCV na mensuração do impacto da doença entre coronariopatas.

scholarly journals Is SF-12 a valid and reliable measurement of health-related quality of life among adults with Marfan syndrome? A confirmatory study

PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0252864
Author(s):  
Nathasha Udugampolage ◽  
Rosario Caruso ◽  
Mariangela Panetta ◽  
Edward Callus ◽  
Federica Dellafiore ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Concurrent Validity ◽  
Short Form ◽  
Health Related Quality ◽  
Short Form Health Survey ◽  
Sf 36 ◽  
Related Quality ◽  
Health Related ◽  
Short Form Health

Introduction The structural validity and reliability of the Short-Form Health Survey 12 (SF-12) has not yet been tested in adults with the Marfan syndrome (MFS). This gap could undermine an evidence-grounded practice and research, especially considering that the need to assess health-related quality of life in patients with MFS has increased due to the improved life expectancy of these patients and the need to identify their determinants of quality of life. For this reason, this study aimed to confirm the dimensionality (structural validity) of the SF-12, its concurrent validity, and its reliability (internal consistency). Methods We performed a cross-sectional study in a convenience sample of 111 Italian adults with MFS, collecting anamnestic and socio-demographic information, the SF-12, and short-form Health Survey 36 (SF-36). A confirmatory factor analysis was performed to verify whether the items of SF-12 related to physical restrictions, physical functioning, and bodily pain were retained by the physical summary component of the SF-12. The items referred to the role limitations due to emotional issues, social functioning, and mental health were retained by the mental summary component (MCS12). SF-36 was used to assess the concurrent validity of SF-12, hypothesizing positive correlations among the equivalent summary scores. Results The two-factor structural solution resulted in fitting the sample statistics adequately. The internal consistency was adequate for the two factors. Furthermore, the physical and mental summary scores of the SF-36 were positively correlated with their equivalent summary scores derived from the SF-12. Conclusions This study confirmed the factor structure of the SF-12. Therefore, the use of SF-12 in clinical practice and research for assessing the health-related quality of life among adults with MFS is evidence-grounded. Future research is recommended to determine whether the SF-12 shows measurement invariance in different national contexts and determine eventual demographic variation in the SF-12 scores among patients with MFS.

Leisure Lifestyle and Health-Related Quality of Life of Taiwanese Adults

2012 ◽  
Vol 40 (2) ◽  
pp. 301-317 ◽  
Author(s):  
Ming-Ching Yang ◽  
Jen-Son Cheng ◽  
Shu-Wen Yu
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Health Related Quality ◽  
Short Form Health Survey ◽  
Sf 36 ◽  
Related Quality ◽  
Health Related ◽  
The Relationship ◽  
Short Form Health

The relationship between various leisure lifestyles (LLS) and health-related quality of life (HRQoL) was analyzed. The 36-Item Short-Form Health Survey (SF-36; Ware, Kosinski, & Keller, 1994) was completed by 622 residents of Taiwan. Factor analysis resulted in 6 dimensions of leisure lifestyle: preferred travel, self-realization, morning action, exercise loving, homebody, and social support. The scores for self-realization were the highest and the scores for morning action the lowest. Cluster analysis was applied to categorize the respondents into 4 leisure lifestyle groups: morning exercisers, traveling and social people, static recreation people, and active exercisers. In general, those groups of people for whom their LLS included more exercise had a better HRQoL.

scholarly journals Validation of a New Questionnaire with Generic and Disease-Specific Qualities: The Mcgill Copd Quality of Life Questionnaire

2012 ◽  
Vol 19 (6) ◽  
pp. 367-372 ◽  
Author(s):  
Smita Pakhale ◽  
Sharon Wood-Dauphinee ◽  
Adriana Spahija ◽  
Jean-Paul Collet ◽  
François Maltais ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Chronic Obstructive ◽  
Life Questionnaire ◽  
Short Form Health Survey ◽  
Related Quality ◽  
Health Related ◽  
Test Retest Reliability ◽  
Short Form Health

BACKGROUND: A validated health-related quality of life questionnaire in chronic obstructive pulmonary disease (COPD) with advantages of both generic- and disease-specific questionnaires is needed to capture patients’ perspectives of severity and impact of the disease. The McGill COPD questionnaire was created to include these advantages in English and French. It assesses three domains: symptoms, physical function and feelings with 29 items (12 from the 36-item Short-Form Health Survey with 17 from the previously developed COPD-specific module).OBJECTIVE: To evaluate the psychometric properties of this newly developed hybrid questionnaire in subjects with COPD.METHODS: Data from a multicentre, prospective cohort study involving four hospitals with COPD subjects undergoing pulmonary rehabilitation were used. Patient evaluations included health-related quality of life (the new McGill COPD questionnaire, the St Georges Respiratory Questionnaire and the 36-item Short-Form Health Survey) and pulmonary function tests pre-and postrehabilitation. Reliability, validity and responsiveness were tested.RESULTS: The study included 246 COPD subjects (111 females) with a mean age of 66 years, 87% ex- and 8% current smokers (mean 61 pack-years) and mean forced expiratory volume in 1 s of 1.12 L (Global initiative for chronic Obstructive Lung Disease stages: 2, 27%; 3, 33%; and 4, 37%). Missing data were <2% and floor and ceiling effects were <5%. Internal consistency (Cronbach’s alpha) was 0.68 to 0.82. Test-retest reliability (intracorrelation coefficients) ranged from 0.74 to 0.96 for the sub-scales, and 0.95 for the total score. Correlation with the St George’s Respiratory Questionnaire was moderately high (r=− 0.88 [95% CI −0.91 to −0.84]), consistent with the a priori hypothesis for convergent validity. The effect size was 0.33 (pre-postrehabilitation mean score difference = 6), suggesting a small to moderate change.CONCLUSIONS: The new McGill COPD questionnaire showed high internal consistency, test-retest reliability, validity and moderate responsiveness in COPD subjects.

scholarly journals Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients

2021 ◽  
pp. 1-10
Author(s):  
Julia M.T. Colombijn ◽  
Anna A. Bonenkamp ◽  
Anita van Eck van der Sluijs ◽  
Joost A. Bijlsma ◽  
Arnold H. Boonstra ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Health Related Quality ◽  
Dialysis Patients ◽  
Self Rated Health ◽  
Significant Difference ◽  
Related Quality ◽  
Health Related ◽  
The Mean

<b><i>Introduction:</i></b> Dialysis patients are often prescribed a large number of medications to improve metabolic control and manage coexisting comorbidities. However, some studies suggest that a large number of medications could also detrimentally affect patients’ health-related quality of life (HRQoL). Therefore, this study aims to provide insight in the association between the number of types of medications and HRQoL in dialysis patients. <b><i>Methods:</i></b> A multicentre cohort study was conducted among dialysis patients from Dutch dialysis centres 3 months after initiation of dialysis as part of the ongoing prospective DOMESTICO study. The number of types of medications, defined as the number of concomitantly prescribed types of drugs, was obtained from electronic patient records. Primary outcome was HRQoL measured with the Physical Component Summary (PCS) score and Mental Component Summary (MCS) score (range 0–100) of the Short Form 12. Secondary outcomes were number of symptoms (range 0–30) measured with the Dialysis Symptoms Index and self-rated health (range 0–100) measured with the EuroQol-5D-5L. Data were analysed using linear regression and adjusted for possible confounders, including comorbidity. Analyses for MCS and number of symptoms were performed after categorizing patients in tertiles according to their number of medications because assumptions of linearity were violated for these outcomes. <b><i>Results:</i></b> A total of 162 patients were included. Mean age of patients was 58 ± 17 years, 35% were female, and 80% underwent haemodialysis. The mean number of medications was 12.2 ± 4.5. Mean PCS and MCS were 36.6 ± 10.2 and 46.8 ± 10.0, respectively. The mean number of symptoms was 12.3 ± 6.9 and the mean self-rated health 60.1 ± 20.6. In adjusted analyses, PCS was 0.6 point lower for each additional medication (95% confidence interval [95% CI]: −0.9 to –0.2; <i>p</i> = 0.002). MCS was 4.9 point lower (95% CI: −8.8 to –1.0; <i>p</i> = 0.01) and 1.0 point lower (95% CI: −5.1–3.1; <i>p</i> = 0.63) for the highest and middle tertiles of medications, respectively, than for the lowest tertile. Patients in the highest tertile of medications reported 4.1 more symptoms than in the lowest tertile (95% CI: 1.5–6.6; <i>p</i> = 0.002), but no significant difference in the number of symptoms was observed between the middle and lowest tertiles. Self-rated health was 1.5 point lower for each medication (95% CI: −2.2 to –0.7; <i>p</i> &#x3c; 0.001). <b><i>Discussion/Conclusion:</i></b> After adjustment for comorbidity and other confounders, a higher number of medications were associated with a lower PCS, MCS, and self-rated health in dialysis patients and with more symptoms.

Sign in / Sign up

Export Citation Format

Share Document